Natera EBITDA Margin 2014-2025 | NTRA
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Natera (NTRA) over the last 10 years. The current EBITDA margin for Natera as of June 30, 2025 is .
| Natera EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $1.97B | $-0.26B | -13.18% |
| 2025-03-31 | $1.83B | $-0.19B | -10.60% |
| 2024-12-31 | $1.70B | $-0.19B | -11.26% |
| 2024-09-30 | $1.53B | $-0.21B | -13.84% |
| 2024-06-30 | $1.36B | $-0.28B | -20.88% |
| 2024-03-31 | $1.21B | $-0.35B | -29.30% |
| 2023-12-31 | $1.08B | $-0.42B | -38.72% |
| 2023-09-30 | $0.99B | $-0.48B | -48.38% |
| 2023-06-30 | $0.93B | $-0.49B | -52.42% |
| 2023-03-31 | $0.87B | $-0.52B | -59.79% |
| 2022-12-31 | $0.82B | $-0.52B | -63.29% |
| 2022-09-30 | $0.78B | $-0.52B | -66.49% |
| 2022-06-30 | $0.72B | $-0.55B | -75.80% |
| 2022-03-31 | $0.67B | $-0.52B | -78.26% |
| 2021-12-31 | $0.63B | $-0.45B | -71.68% |
| 2021-09-30 | $0.56B | $-0.38B | -67.91% |
| 2021-06-30 | $0.50B | $-0.29B | -57.94% |
| 2021-03-31 | $0.45B | $-0.23B | -50.67% |
| 2020-12-31 | $0.39B | $-0.20B | -51.54% |
| 2020-09-30 | $0.36B | $-0.16B | -45.43% |
| 2020-06-30 | $0.34B | $-0.13B | -37.83% |
| 2020-03-31 | $0.33B | $-0.11B | -33.13% |
| 2019-12-31 | $0.30B | $-0.11B | -35.43% |
| 2019-09-30 | $0.29B | $-0.10B | -36.01% |
| 2019-06-30 | $0.27B | $-0.11B | -39.93% |
| 2019-03-31 | $0.26B | $-0.11B | -41.22% |
| 2018-12-31 | $0.26B | $-0.11B | -41.25% |
| 2018-09-30 | $0.24B | $-0.12B | -50.83% |
| 2018-06-30 | $0.23B | $-0.12B | -52.36% |
| 2018-03-31 | $0.22B | $-0.12B | -55.41% |
| 2017-12-31 | $0.21B | $-0.13B | -61.24% |
| 2017-09-30 | $0.20B | $-0.12B | -60.89% |
| 2017-06-30 | $0.20B | $-0.12B | -62.00% |
| 2017-03-31 | $0.20B | $-0.12B | -59.50% |
| 2016-12-31 | $0.21B | $-0.09B | -44.13% |
| 2016-09-30 | $0.22B | $-0.07B | -31.67% |
| 2016-06-30 | $0.21B | $-0.06B | -30.19% |
| 2016-03-31 | $0.21B | $-0.06B | -27.80% |
| 2015-12-31 | $0.19B | $-0.05B | -28.42% |
| 2015-06-30 | $0.14B | $-0.01B | -9.42% |
| 2015-03-31 | $0.13B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $22.743B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.686B | 27.39 |
| CVS Health (CVS) | United States | $90.749B | 11.28 |
| Elevance Health (ELV) | United States | $69.812B | 9.39 |
| Cencora (COR) | United States | $56.166B | 18.70 |
| DiDi Global (DIDIY) | China | $27.862B | 29.60 |
| Labcorp Holdings (LH) | United States | $23.139B | 18.39 |
| BioMerieux (BMXMF) | France | $17.423B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.474B | 0.00 |
| ICON (ICLR) | Ireland | $13.871B | 13.35 |
| Medpace Holdings (MEDP) | United States | $13.184B | 34.89 |
| CochLear (CHEOY) | Australia | $12.924B | 0.00 |
| Solventum (SOLV) | United States | $12.643B | 13.05 |
| Viatris (VTRS) | United States | $12.137B | 4.32 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.796B | 0.00 |
| Revvity (RVTY) | United States | $10.589B | 18.66 |
| Avantor (AVTR) | United States | $9.067B | 13.30 |
| Charles River Laboratories (CRL) | United States | $8.057B | 15.29 |
| Sonic Healthcare (SKHHY) | Australia | $7.725B | 0.00 |
| HealthEquity (HQY) | United States | $7.725B | 33.84 |
| Bausch + Lomb (BLCO) | Canada | $5.112B | 34.38 |
| Sotera Health (SHC) | United States | $4.658B | 26.03 |
| BrightSpring Health Services (BTSG) | United States | $4.246B | 32.39 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.627B | 83.06 |
| Alignment Healthcare (ALHC) | United States | $3.105B | 0.00 |
| KindlyMD (NAKA) | United States | $3.035B | 0.00 |
| Concentras Parent (CON) | United States | $2.930B | 18.58 |
| Surgery Partners (SGRY) | United States | $2.909B | 36.60 |
| Organon (OGN) | United States | $2.358B | 2.57 |
| Premier (PINC) | United States | $2.129B | 19.74 |
| Progyny (PGNY) | United States | $1.947B | 41.16 |
| Ardent Health (ARDT) | United States | $1.793B | 6.92 |
| PACS (PACS) | United States | $1.777B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.504B | 25.47 |
| Pediatrix Medical (MD) | United States | $1.483B | 9.90 |
| Teladoc Health (TDOC) | United States | $1.380B | 0.00 |
| Omada Health (OMDA) | $1.246B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.210B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.831B | 4.87 |
| AMN Healthcare Services Inc (AMN) | United States | $0.780B | 9.64 |
| CareDx (CDNA) | United States | $0.682B | 12.56 |
| Performant Healthcare (PHLT) | United States | $0.600B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.524B | 0.00 |
| Agilon Health (AGL) | United States | $0.510B | 0.00 |
| Nutex Health (NUTX) | United States | $0.500B | 7.57 |
| Sonida Senior Living (SNDA) | United States | $0.495B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.493B | 84.50 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.457B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.455B | 6.83 |
| So-Young (SY) | China | $0.433B | 0.00 |
| SBC Medicals (SBC) | United States | $0.426B | 9.32 |
| Enhabit (EHAB) | United States | $0.402B | 26.47 |
| Oncology Institute (TOI) | United States | $0.326B | 0.00 |
| LifeMD (LFMD) | United States | $0.308B | 0.00 |
| Beauty Health (SKIN) | United States | $0.257B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.227B | 0.00 |
| DocGo (DCGO) | United States | $0.161B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.149B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.115B | 0.00 |
| Biodesix (BDSX) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.025B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.021B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| ModivCare (MODV) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |